New shot targets cellulite: small study tests qwo on butt and thighs
NCT ID NCT05026216
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed Phase 4 study tested multiple doses of Qwo, a drug made from bacterial enzymes, for treating mild to moderate cellulite in adult women. Five participants received injections in their buttocks and thighs over three sessions. The goal was to see if the treatment improved the look of cellulite as judged by a doctor.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Qwo (collagenase clostridium histolyticum-aaes)
- What this could lead to
- If it works, this could offer a non-surgical option to reduce the appearance of cellulite on buttocks and thighs.
- What could go wrong
- This is a very small, early-phase study with only 5 participants, so results may not apply to everyone. Cellulite treatments often show modest improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELLULITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DMR Research, PLLC
Westport, Connecticut, 06880, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.